Canada markets closed

CaliPharms, Inc. (KGET)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.00000.0000 (0.00%)
At close: 10:25AM EDT

CaliPharms, Inc.

33175 Temecula Parkway
Suite A 8019
Temecula, CA 92592
United States
949-800-6645

Sector(s)
Industry
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Brian Wayne GeerSecretary and DirectorN/AN/A1980
Mr. Bo LintonPresident & ChairmanN/AN/A1970
Mr. Eric WatsonChief Executive OfficerN/AN/A1969
Ms. Maxine PiersonExecutive VP In Charge of Mergers & Acquisitions and Member of Advisory BoardN/AN/AN/A
Amounts are as of December 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

CaliPharms, Inc. engages in the medicinal Cannabis Industry in the United States. It focuses on the THC and CBD beverage industry. The company was formerly known as Kleangas Energy Technologies, Inc. and changed its name to CaliPharms, Inc. in January, 2017. CaliPharms, Inc. is based in Temecula, California.

Corporate Governance

CaliPharms, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.